ACT-539313

Idorsia drug fails to quell binge eating in midphase trial, driving biotech to abandon the indication
Fierce Biotech
Tue, 05/10/22 - 10:39 am
Idorsia
clinical trials
ACT-539313
binge eating disorder
Actelion